Financhill
Back

Global Blood Therapeutics Stock Predictions

Buy
71

GBT
Global Blood Therapeutics

Last Price:
67.02
Seasonality Move:
-5.93%

7 Day Trial

ALL ACCESS PASS

$ 7

Global Blood Therapeutics Stock Forecast

  • Over the next 52 weeks, Global Blood Therapeutics has on average historically risen by 13.5% based on the past 5 years of stock performance.
  • Global Blood Therapeutics has risen higher in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
  • Is Global Blood Therapeutics Stock Undervalued?
    The current Global Blood Therapeutics [GBT] share price is $67.00. The Score for GBT is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • GBT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Global Blood Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Global Blood Therapeutics has on average historically risen by 13.5% based on the past 5 years of stock performance.

Global Blood Therapeutics Stock Rating

Buy
71
Global Blood Therapeutics (GBT) is a Buy

Is Global Blood Therapeutics overpriced?

  • Global Blood Therapeutics has risen higher in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%

Global Blood Therapeutics Stock Price History

Is GBT stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GBT is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
gbt.com

52-Week Data

52-Week High:
73.02
52-Week Low:
21.65

Prediction Charts

Market Cap:
4.52B
Price in USD:
67.00
Volume:
4.79M
Beta:
1.21

Technical Analysis

SMA50:
36.73
SMA100:
33.87
SMA200:
32.08
52-Wk Change:
149.35%

Stock Predictions

  • Is Global Blood Therapeutics stock public?
    Yes, Global Blood Therapeutics is a publicly traded company.
  • What is the Global Blood Therapeutics stock quote today?
    The Global Blood Therapeutics stock price isĀ 67.00 USD today.
  • How to buy Global Blood Therapeutics stock online?
    You can buy Global Blood Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jul-27 33.44 34.03 34.42 32.94
Jul-29 32.43 32.72 32.81 31.58
Aug-1 31.51 32.40 33.65 31.51
Aug-2 32.34 32.93 33.23 32.10
Aug-3 33.40 33.93 34.82 33.38
Aug-4 44.10 47.99 48.49 43.53
Aug-5 47.41 63.84 73.02 46.57
Aug-8 66.69 66.60 66.77 66.55
Aug-9 66.53 66.59 66.66 66.46
Aug-10 66.64 66.84 66.87 66.58
Aug-11 66.86 66.57 66.90 66.50
Aug-12 66.67 66.75 66.81 66.59
Aug-15 66.71 67.04 67.28 66.68
Aug-16 66.98 67.00 67.19 66.94

Global Blood Therapeutics Earnings

Global Blood Therapeutics Earnings Report: Per Share Global Blood Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Global Blood Therapeutics Forecast Revenue Growth

Global Blood Therapeutics Stock Analysis: Historical quarterly revenues per share for Global Blood Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.22 per share, and an increase next year of $1.81 per share.

* Global Blood Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.